Kamfose, M.M.; Muriithi, F.G.; Knight, T.; Lasserson, D.; Hayward, G.
Intravenous Ceftriaxone Versus Multiple Dosing Regimes of Intravenous Anti-Staphylococcal Antibiotics for Methicillin-Susceptible Staphylococcus aureus (MSSA): A Systematic Review. Antibiotics 2020, 9, 39.
https://doi.org/10.3390/antibiotics9020039
AMA Style
Kamfose MM, Muriithi FG, Knight T, Lasserson D, Hayward G.
Intravenous Ceftriaxone Versus Multiple Dosing Regimes of Intravenous Anti-Staphylococcal Antibiotics for Methicillin-Susceptible Staphylococcus aureus (MSSA): A Systematic Review. Antibiotics. 2020; 9(2):39.
https://doi.org/10.3390/antibiotics9020039
Chicago/Turabian Style
Kamfose, Musaiwale M., Francis G. Muriithi, Thomas Knight, Daniel Lasserson, and Gail Hayward.
2020. "Intravenous Ceftriaxone Versus Multiple Dosing Regimes of Intravenous Anti-Staphylococcal Antibiotics for Methicillin-Susceptible Staphylococcus aureus (MSSA): A Systematic Review" Antibiotics 9, no. 2: 39.
https://doi.org/10.3390/antibiotics9020039
APA Style
Kamfose, M. M., Muriithi, F. G., Knight, T., Lasserson, D., & Hayward, G.
(2020). Intravenous Ceftriaxone Versus Multiple Dosing Regimes of Intravenous Anti-Staphylococcal Antibiotics for Methicillin-Susceptible Staphylococcus aureus (MSSA): A Systematic Review. Antibiotics, 9(2), 39.
https://doi.org/10.3390/antibiotics9020039